New cell therapy takes on tough stomach and colon cancers
NCT ID NCT07166263
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 29 times
Summary
This early-phase study tests a new cell therapy called NK510 in 15 people with advanced stomach or colorectal cancer that has not responded to or returned after at least two prior treatments. The therapy is given through an IV or directly into the abdomen. The main goals are to check safety and see if tumors shrink or stop growing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanjing Drum Tower Hospital, Affiliated to the Medical School of Nanjing University
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.